Skip to main content
SpringerLink
Log in

Intellectual property—the dispute between research institutions and voluntary health agencies

  • Commentary
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

A Corrigendum to this article was published on 01 July 2004

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Medicine and of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, USA

    Marshall A Lichtman

  2. Research and Medical Programs, The Leukemia & Lymphoma Society, White Plains, NY

    Marshall A Lichtman

  3. Director, Office of Technology Transfer, University of Rochester Medical Center, Rochester, New York, USA

    Marjorie D Hunter

  4. Director, Office of Research and Project Administration, University of Rochester, Rochester, New York, USA

    Gunta J Liders

Authors
  1. Marshall A Lichtman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marjorie D Hunter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gunta J Liders
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lichtman, M., Hunter, M. & Liders, G. Intellectual property—the dispute between research institutions and voluntary health agencies. Nat Biotechnol 22, 385–386 (2004). https://doi.org/10.1038/nbt0404-385

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0404-385

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation